We're excited to announce the appointment of Dave Ricks as Lilly's next president and CEO, effective January 1, 2017. A 20-year Lilly veteran, Dave is a capable, decisive and energetic leader who brings a wealth of experience to his new role. Previously the leader of Lilly affiliates in the U.S., China and Canada, he has been president of Lilly's Bio-Medicines unit since January 2012. Dave currently serves on the board of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and has served as co-chair of the Trans-Atlantic Business Dialogue. With a deep understanding of product development, global sales and marketing, and public policy, Dave will provide outstanding leadership for Lilly in the coming years.
We invite you to learn more about Dave, our transition plans and our promise for the future.